NKTX Competitors & Alternatives
Compare Nkarta Inc with similar stocks in the same industry
Biotechnology
NKTX
Main Stock$1.48
Tradestie Score
43
Market Cap
$151.28M
Analyst Upside
+609.5%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.00
|
$154.27M | - | 48 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$2.89
|
$153.02M | - | 40 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.25
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.88
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$31.15
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.78
|
$97.42M | - | 33 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.12
|
$96.93M | - | 42 | Compare |
|
PLRX
Pliant Therapeutics, Inc. Common Stock
|
$0.78
|
$89.01M | - | 39 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.66
|
$67.94M | - | 46 | Compare |
More NKTX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry